Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-227
Closed -$2K 5362
2019
Q2
$2K Hold
227
﹤0.01% 4987
2019
Q1
$2K Sell
227
-81
-26% -$739 ﹤0.01% 4961
2018
Q4
$3K Sell
308
-167
-35% -$1.92K ﹤0.01% 4720
2018
Q3
$8K Sell
475
-345
-42% -$4.38K ﹤0.01% 4387
2018
Q2
$9K Buy
820
+79
+11% +$903 ﹤0.01% 4126
2018
Q1
$9K Buy
741
+149
+25% +$1.79K ﹤0.01% 4145
2017
Q4
$7K Buy
592
+29
+5% +$328 ﹤0.01% 4276
2017
Q3
$6K Hold
563
﹤0.01% 4203
2017
Q2
$9K Sell
563
-245
-30% -$4.59K ﹤0.01% 3979
2017
Q1
$15K Hold
808
﹤0.01% 3543
2016
Q4
$9K Hold
808
﹤0.01% 3668
2016
Q3
$7K Buy
808
+322
+66% +$3K ﹤0.01% 3754
2016
Q2
$3K Buy
+486
New +$6.98K ﹤0.01% 3978

Other funds holding MESO

Advisor Group's MESO Position: Q3 2019 in Review

Advisor Group sold out of Mesoblast (MESO) in Q3 2019, closing a stake of 227 shares — an estimated $2K sold.

Advisor Group first reported a position in MESO in Q2 2016 and held it in 13 quarters. The position peaked at $15K in Q1 2017. 30 funds tracked by Wall St. Rank hold MESO as of Q3 2019.

  • Advisor Group reported no remaining Mesoblast position as of Q3 2019 after selling out during the quarter.
  • Advisor Group sold 227 Mesoblast shares in Q3 2019, an estimated $2K.
  • Advisor Group first reported a position in Mesoblast in Q2 2016 and held it in 13 quarters.
  • Advisor Group's Mesoblast position peaked at $15K in Q1 2017.
  • 30 funds tracked by Wall St. Rank held Mesoblast as of Q3 2019.

Based on Advisor Group's 13F filing for Q3 2019, filed 13 Nov 2019.